Innovative Imaging Esaote is actively expanding its ultrasound and dedicated MRI portfolio with new systems and analytics capabilities, including the Prostate Attention Map (PAM) and MyLab E85 GTS, creating cross-sell opportunities for advanced imaging and guided therapy solutions in urology and oncology.

Guided Therapy Growth Recent launches and presentations at EAU, ECR and AANS highlight a strategic push into ultrasound-guided procedures and interventional radiology, signaling demand for training, integration services, and workflow optimization around guided therapy systems.

Urology Focus PAM technology and dedicated urology systems position Esaote to pursue targeting clinics and hospital departments focusing on prostate care, enabling specialized sales efforts around image quality, fusion workflows, and precision-guided interventions.

Strategic Leadership Senior leadership changes and North American growth initiatives suggest opportunities to engage with regional teams on channel partnerships, service contracts, and expansion plans to capture untapped markets and ensure ongoing support for new platforms.

Digital & Cloud Readiness Existing tech stack and cloud-based data management capabilities (AWS, Azure, SQL, MongoDB) indicate potential for selling analytics, remote monitoring, and IT-enabled service offerings to improve device uptime, data interoperability, and imaging informatics across facilities.